Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, GKB Ophthalmics has informed that the Audit Committee in their meeting held on September 07, 2020, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there is no deviation or variation in the use of proceeds, during the quarter ended June 30, 2020.
The above information is a part of company’s filings submitted to BSE.
